Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Third Vaccination of FSME-IMMUN NEW
NCT00161876Phase 3Completed
- Sponsor
- Pfizer
- Start
- May 2002
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Tick-borne encephalitis vaccine in tick-borne encephalitis (TBE), sponsored by Pfizer. Started May 2002; status: completed.
02
Drugs
Tick-borne encephalitis vaccine
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on NCT00161876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00161876.